Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study (Q34255166)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 27, 2010

Language	Label	Description	Also known as
English	Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study	scientific article published on July 27, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

14

object named as

Hyo Seop Ahn

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Seok Jin Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jong Wook Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Chul Won Jung

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Chang Ki Min

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Bin Cho

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ho Jin Shin

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Joo Seop Chung

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hawk Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Won Sik Lee

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Young Don Joo

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Deok-Hwan Yang

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hoon Kook

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hyoung Jin Kang

13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sung-Soo Yoon

15

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sang Kyun Sohn

16

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Yoo Hong Min

17

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Woo-Sung Min

18

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hee-Sook Park

19

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jong Ho Won

20

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20663943

11 June 2024

publication date

27 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

full work available at URL

https://haematologica.org/article/download/5791/27682

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

http://www.haematologica.org/journal/2010/951935.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

http://www.haematologica.org/journal/2010/11/1935.html

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20663943/pdf/?tool=EBI

Portable Document Format

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20663943/?tool=EBI

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

https://europepmc.org/articles/PMC2966917

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

https://europepmc.org/articles/PMC2966917?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

https://doi.org/10.3324/haematol.2010.026104

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

95

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1935-1942

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Quality of life after allogeneic hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

High levels of B-cell activating factor in patients with active chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Treatment of refractory chronic GVHD with rituximab: a GITMO study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Hematopoietic stem-cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Rituximab for steroid-refractory chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Chronic graft-versus-host disease: clinical manifestation and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

How I treat chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Quality of life following bone marrow transplantation: a comparison of patient reports with population norms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

How large should a phase II trial of a new drug be?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

28 October 2018

Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

28 October 2018

Chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

28 October 2018

Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

28 October 2018

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/20663943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20663943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20663943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20663943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab as salvage therapy for refractory chronic GVHD

1 reference

https://pubmed.ncbi.nlm.nih.gov/20663943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/20663943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2010.026104

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34255166&oldid=2176627260"